0001620965-14-000001.txt : 20141010 0001620965-14-000001.hdr.sgml : 20141010 20141010145726 ACCESSION NUMBER: 0001620965-14-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20141010 DATE AS OF CHANGE: 20141010 EFFECTIVENESS DATE: 20141010 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ASPEN PARK PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001620965 IRS NUMBER: 471247238 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-226229 FILM NUMBER: 141152223 BUSINESS ADDRESS: STREET 1: 944 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10028 BUSINESS PHONE: 914-552-2651 MAIL ADDRESS: STREET 1: 944 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10028 D 1 primary_doc.xml X0707 D LIVE 0001620965 ASPEN PARK PHARMACEUTICALS, INC. 944 PARK AVENUE NEW YORK NY NEW YORK 10028 914-552-2651 DELAWARE None None Corporation true 2014 Mitchell S. Steiner c/o Aspen Park Pharmaceuticals, Inc. 944 Park Ave. New York NY NEW YORK 10028 Executive Officer Director Chief Executive Officer Harry Fisch, MD c/o Aspen Park Pharmaceuticals, Inc. 944 Park Ave. New York NY NEW YORK 10028 Executive Officer Director Chief Scientific Officer Pharmaceuticals No Revenues 06b false true false true false 0 20000000 0 20000000 false 0 0 0 0 false ASPEN PARK PHARMACEUTICALS, INC. c/o Harry Fisch Harry Fisch, MD Chief Scientific Officer 2014-09-29